OurCrowd, the world’s leading equity crowdfunding platform has announced
that Joel Maryles has joined as a Venture Partner to work with
OurCrowd's portfolio companies on strategic issues including financings,
partnerships, IPOs as well as M&A. He will carry the title of Chief Exit
Officer (CXO).
In his three decade Wall Street career, Maryles was involved in $20B of
transactions for Israeli tech companies including deals for leading
companies, such as M-Systems, Teva, Galileo, Given Imaging, and Nice.
Maryles founded Citigroup's Israel Investment Banking operations and
managed it for over a decade, completing over sixty
successful transactions, including IPOs, follow-on equity offerings, and
merger and acquisitions.
Jon Medved, CEO of OurCrowd said, "With the addition of
Joel Maryles we continue to build our team of extraordinary
professionals with strong backgrounds. Joel will provide our portfolio
of 60 startups with significant access to Wall Street and strategic
finance expertise, and help them navigate the road to exit.”
Joel Maryles commented, "I have had the pleasure for thirty years to
work with and invest in leading-edge technology and healthcare
companies, both in Israel and the US. OurCrowd has built an
impressive stable of companies with exciting technology and bright
prospects. I look forward to working with these companies,
drawing upon the knowledge and experience that I have gathered over my
career on Wall Street, to help them grow and achieve their goals.”
Maryles currently serves as a board member of Radware (NASDAQ: RDWR), a
provider of application delivery and network security products, and of
EZchip (NASDAQ: EZCH), a fabless semiconductor company that
provides Ethernet network processors for networking equipment.
Maryles holds a Bachelor of Science degree in Engineering from the
University of Illinois and a Master of Business Administration from the
University of Chicago.
About OurCrowd:
OurCrowd is the world's largest equity
crowdfunding platform for accredited investors to invest in Israeli and
global companies. Managed by a team of well-known investment
professionals and led by serial entrepreneur Jon Medved, OurCrowd vets
and selects opportunities, invests its own capital and brings these
startups to its accredited membership. OurCrowd investors must meet
stringent accreditation criteria and invest a minimum of $10,000 per
deal of their choice. OurCrowd provides post-investment support to its
portfolio companies, assigning industry experts as mentors and taking
board seats. OurCrowd has raised over $110M in equity crowdfunding for
its 62 portfolio companies, which include leading companies, such as:
Borro, BillGuard, Consumer Physics (SCiO), BioCatch, Abe’s Market, and
ReWalk, OurCrowd’s first portfolio company to complete a successful IPO
on the NASDAQ. Visit us online at: www.ourcrowd.com.
For Press Materials: http://blog.ourcrowd.com/index.php/press-release-joel-maryles/
Copyright Business Wire 2015